Vaccines based on bacterial vectors present antigens carried by APCs and are recognized by T cells, which activate CD4+ and CD8+ T cells, thereby enhancing the immune response and inducing apoptosis of tumor cells [20,21,22,23,24]. The gene discussed is CD8A; the disease is neoplasm.